Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Eur Urol. 2018 Sep 17;75(2):221–228. doi: 10.1016/j.eururo.2018.08.039

Fig. 1 –

Fig. 1 –

(A) Unadjusted rate of patients reporting erectile function recovery at 12 (red line) and 24 (blue line) mo after radical prostatectomy (RP). (B) Rate of patients reporting regular use of phosphodiesterase type 5 inhibitors at 12 (red line) and 24 (blue line) mo assessment. (C) Rate of patients treated with different surgical approach: open RP (red line); laparoscopic RP (blue); robot-assisted RP (green).

EF = erectile function.